Description of Medical ServiceTesting of tumour tissue by a pathologist, for patients with locally advanced or metastatic Cholangiocarcinoma, to detect IDH1 mutations. Confirmation of the disease will be required to determine eligibility for treatment with TibsovoŽ (ivosidenib), which is seeking PBS listing through a codependent submission.
Description of Medical ConditionCholangiocarcinoma is a type of cancer that encompasses all tumours originating from the epithelium of the bile duct. Bile ducts are a group of thin tubes that carry bile (a digestive fluid) from the liver and gallbladder into the intestines.
Reason for ApplicationNew MBS item
Medical Service TypeInvestigative technology
Previous Application Number/sNot Applicable
Application Summary and PICO SetApplication Summary (PDF 401 KB)
Application Summary (Word 27 KB)
PICO Set (PDF 834 KB)
PICO Set (Word 300 KB)
Consultation SurveyConsultation Survey (PDF 654 KB)
Consultation Survey (Word 27 KB)
PASC consultation closes 7 July 2023
MSAC consultation TBA – please subscribe to the MSAC Email Bulletin to be notified when consultation opens for this application
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process